Pharmac’s latest breast cancer drug funding ‘way short’

On Wednesday Pharmac announced $190 million to fund most cancers treatment plans and other medicines. File photo. (Supply: istock.com) Bundled in the funding is Trastuzumab emtansine (model identify Herceptin) to address breast most cancers in the early phases. But Breast Most cancers Aotearoa Coalition chair Libby Burgess states the funding allocation suggests breast most cancers […]